Department of Justice December 9, 2022 – Federal Register Recent Federal Regulation Documents
Results 1 - 2 of 2
Schedules of Controlled Substances: Placement of Methiopropamine in Schedule I
With the issuance of this final rule, the Drug Enforcement Administration places N-methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine), including its salts, isomers, and salts of isomers in schedule I of the Controlled Substances Act. This action is being taken to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle methiopropamine.
Agency Information Collection Activities; Proposed eCollection; eComments Requested; Revision of a Currently Approved Collection; Request for New Recognition, Renewal of Recognition, Extension of Recognition of a Non-Profit Religious, Charitable, Social Service, or Similar Organization (Form EOIR-31)
The Executive Office for Immigration Review (EOIR), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on November 3, 2022, allowing for a 30-day comment period, however the email address for comments was incorrect. This notice corrects the email address and extends the period for comment.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
